Article Text

PDF
Periacinar retraction clefting in proliferative prostatic atrophy and prostatic adenocarcinoma
  1. Monika Ulamec1,
  2. Davor Tomas1,
  3. Christian Ensinger2,
  4. Hrvoje Čupić1,
  5. Mladen Belicza1,
  6. Gregor Mikuz2,
  7. Božo Krušlin1
  1. 1Ljudevit Jurak Department of Pathology, Sestre milosrdnice University Hospital, Zagreb, Croatia
  2. 2Institute of Pathology, Medical University Innsbruck, Innsbruck, Austria
  1. Professor Božo Krušlin, Ljudevit Jurak Department of Pathology, Sestre milosrdnice University Hospital, Vinogradska cesta 29, 10 000 Zagreb, Croatia; bkruslin{at}kbsm.hr

Abstract

Aims: To evaluate the presence and extent of periacinar retraction clefting in proliferative prostatic atrophy and carcinoma in radical prostatectomy specimens.

Methods: Atrophic foci and neoplastic glands were analysed in specimens from 50 patients who underwent radical prostatectomy. Analysed atrophic glands were classified in two main groups, proliferative atrophy (PA) and proliferative inflammatory atrophy (PIA); each group was subclassified into simple atrophy (SA) and postatrophic hyperplasia (PAH). According to the presence and extent of periacinar retraction clefting, atrophic and neoplastic glands were classified as: group 1, glands without clefts or with clefts affecting ⩽50% of gland circumference; group 2, glands with clefts that affected >50% of the circumference in <50% of examined glands; and group 3, glands with clefts that affected >50% of the circumference in ⩾50% of examined glands.

Results: Forty-four (88.0%) atrophic foci were without periacinar clefts or clefts were present in less than half of the gland circumference (group 1). In 6 (12.0%), atrophic foci clefts affected >50% of gland circumference (groups 2 and 3). Forty-five (90.0%) carcinomas were with clefts which affected more than 50% of gland circumference (groups 2 and 3); and in five carcinomas only, clefts were not found or affected <50% of gland circumference (group 1).

Conclusion: Results indicate that periacinar retraction clefting represents a reliable criterion in differential diagnosis between proliferative atrophy and carcinoma.

  • prostatic adenocarcinoma
  • prostatic atrophy
  • retraction clefting
  • PA, proliferative atrophy
  • PAH, postatrophic hyperplasia
  • PIA, proliferative inflammatory atrophy
  • SA, simple atrophy

Statistics from Altmetric.com

Footnotes

  • Funding: Supported by Grants 0108001/02 and 0134002/02 from the Ministry of Science and Technology, Republic of Croatia.

  • Competing interests: None declared.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.